The role of Ang/Tie signaling in lymphangiogenesis

Lymphology

Volumn 43, Issue 2, 2010, Pages 59-72

  Wu, X ^a   Liu, Ning Fei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Ang Tie2 signaling; Lymphangiogenesis; Lymphatic

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN 3; ANGIOPOIETIN 4; ANGIOPOIETIN RECEPTOR; CYTOKINE; FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE C; TIE 1 RECEPTOR; TIE RECEPTOR; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

AUTOPHOSPHORYLATION; BLOOD PRESSURE; BLOOD VESSEL TONE; CANCER INVASION; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL SUBPOPULATION; FOCAL ADHESION; HEART MUSCLE; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; KNOCKOUT MOUSE; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SMOOTH MUSCLE FIBER; STEM CELL; TISSUE REPAIR; TUMOR CELL; ANIMAL; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANGIOPOIETINS; ANIMALS; HUMANS; LYMPHANGIOGENESIS; MICE; RECEPTOR, TIE-2; SIGNAL TRANSDUCTION;

EID: 77955454404     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (151)

1. Alitalo, K, T Tammela, TV Petrova: Lymphangiogenesis in development and human disease. Nature 438 (2005), 946-953.
2. Cursiefen, C, L Chen, MR Dana, et al: Corneal lymphangiogenesis: Evidence, mechanisms, and implications for corneal transplant immunology. Cornea 22 (2003), 273-281. (Pubitemid 36359171)
3. Witte, MH, MJ Bernas, CP Martin, et al: Lymphangiogenesis and lymphangiodysplasia: From molecular to clinical lymphology. Microsc. Res. Tech. 55 (2001), 122-145.
4. Rockson, SG: Diagnosis and management of lymphatic vascular disease. J. Am. Coll. Cardiol. 52 (2008), 799-806.
5. Mäkinen, T, C Norrmén, T Petrova: Molecular mechanisms of lymphatic vascular development. Cell. Mol. Life Sci. 64 (2007), 1915-1929.
6. Karkkainen, MJ, P Haiko, K Alitalo, et al: Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5 (2004), 74-80.
7. Sato, A, A Iwama, T Suda, et al: Characterization of TEK receptor tyrosine kinase and its ligands, angiopoietins, in human hematopoietic progenitor cells. Int. Immunol. 10 (1998), 1217-1227.
8. Yancopoulos, GD, S Davis, J Holash, et al: Vascular specific growth factors and blood vessel formation. Nature 407 (2000), 242-248.
9. Jones, N, K Iljin, K Alitalo, et al: Tie receptors: New modulators of angiogenic and lymphangiogenic responses. Nat. Rev. Mol. Cell. Biol. 2 (2001), 257-267.
10. Ward, NL, DJ Dumont: The angiopoietins and Tie2/Tek: Adding to the complexity of cardiovascular development. Sem. Cell Dev. Biol. 13 (2002), 19-27.
11. Gale, NW, G Thurston, GD Yancopoulos, et al: Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev. Cell. 3 (2002), 411-423.
12. Shimoda, H, MJ Bernas, S Kato, et al: Abnormal recruitment of periendothelial cells to lymphatic capillaries in digestive organs of angiopoietin-2-deficient mice. Cell Tissue Res. 328 (2007), 329-337. (Pubitemid 46452201)
13. Dellinger, M, R Hunter, M Witte, et al: Defective remodeling and maturation of the lymphatic vasculature in angiopoietin-2 deficient mice. Dev. Biol. 319 (2008), 309-320.
14. Davis, S, TH Aldrich, GD Yancopoulos, et al: Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87 (1996), 1161-1169. (Pubitemid 27010100)
15. Davis, S, N Papadopoulos, GD Yancopoulos, et al: Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat. Struct. Biol. 10 (2003), 38-44.
16. Cho, CH, RA Kammerer, GY Koh, et al: COMPAng1: A designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc. Natl. Acad. Sci. USA. 101 (2004), 5547-5552.
17. Kim, KT, HH Choi, GY Koh, et al: Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2. J. Biol. Chem. 280 (2005), 20126-20131.
18. Jones, PF: Not just angiogenesis - wider roles for the angiopoietins. J. Pathol. 201 (2003), 515-527.
19. Maisonpierre, PC, C Suri, PF Jones, et al: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277 (1997), 55-60.
20. Valenzuela, DM, JA Griffiths, J Rojas, et al: Angiopoietin 3 and 4: Diverging gene counterparts in mice and humans. Proc. Natl. Acad. Sci. USA. 96 (1999), 1904-1909.
21. Lee, HJ, CH Cho, GY Koh, et al: Biological characterization of angiopoietin-3 and angiopoietin-4. FASEB J. 18 (2004), 1200-1208.
22. Fiedler, U, HG Augustin: Angiopoietins: A link between angiogenesis and inflammation. Trends Immunol. 27 (2006), 552-558.
23. Kim, KE, CH Cho, GY Koh, et al: In vivo actions of angiopoietins on quiescent and remodeling blood and lymphatic vessels in mouse airways and skin. Arterioscler. Thromb. Vasc. Biol. 27 (2007), 564-570.
24. Thurston, G, C Suri, DM, McDonald, et al: Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286 (1999), 2511-2514. (Pubitemid 30026340)
25. Thurston, G, JS Rudge, E Loffe, et al: Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6 (2000), 460-463.
26. Fukuhara, S, K Sako, T Minami, et al: Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat. Cell. Biol. 10 (2008), 513-526.
27. Saharinen, P, L Eklund, J Miettinen, et al: Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat. Cell. Biol. 10 (2008), 527-537.
28. Sako, K, S Fukuhara, T Minami, et al: Angiopoietin-1 induces Kruppel-like factor 2 expression through a phosphoinositide 3-kinase/AKT-dependent activation of myocyte enhancer factor 2. J. Biol. Chem. 284 (2009), 5592-5601.
29. Ramsauer, M, PA D'Amore: Getting Tie (2) d up in angiogenesis. J. Clin. Invest. 110 (2002), 1615-1617.
30. Jeon, BH, F Khanday: Tie-ing the antiinflammatory effect of angiopoietin-1 to inhibition of NF-kappaB. Circ Res. 92 (2003), 586-588.
31. Gamble, JR, J Drew: Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ. Res. 87 (2000), 603-607.
32. Nykänen, AI, R Krebs, KB Lemström, et al: Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis. Circulation 107 (2003), 1308-1314.
33. Metcalf, DJ, TD Nightingale, HL Zenner, et al: Formation and function of Weibel-Palade bodies. J. Cell. Sci. 121 (2008), 19-27.
34. Fiedler, U, M Scharpfenecker, S Koidl, et al: The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 103 (2004), 4150-4156. (Pubitemid 38685356)
35. Holash, J, PC Maisonpierre, SJ Wiegand, et al: Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284 (1999), 1994-1998.
36. Lobov, IB, PC Brooks, RA Lang, et al: Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc. Natl. Acad. Sci. USA. 99 (2002), 11205-11210.
37. Fiedler, U, YM Reiss, HG Augustin, et al: Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat. Med. 12 (2006), 235-239.
38. Bhandari, V, R Choo-Wing, JA Elias, et al: Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat. Med. 12 (2006), 1286-1293.
39. Scharpfenecker, M, U Fiedler, HG Augustin, et al: The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J. Cell. Sci. 118 (2005), 771-780.
40. Peters, KG, CD Kontos, PC Lin, et al: Functional significance of Tie2 signaling in the adult vasculature. Recent Prog. Horm. Res. 59 (2004), 51-71.
41. Augustin, HG, GY Koh, K Alitalo, et al: Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat. Rev. Mol. Cell. Biol. 10 (2009), 165-177.
42. Ferrara, N: Vascular endothelial growth factor. Arterioscler. Thromb. Vasc. Biol. 29 (2009), 789-791.
43. Iljin, K, TV Petrova, K Alitalo, et al: A fluorescent Tie1 reporter allows monitoring of vascular development and endothelial cell isolation from transgenic mouse embryos. FASEB J. 16 (2002), 1764-1774. (Pubitemid 35340357)
44. Saharinen, P, K Kerkelä, K Alitalo, et al: Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2. J. Cell. Biol. 169 (2005), 239-243.
45. Qu, X, K Tompkins, E Lorene, et al: Abnormal embryonic lymphatic vessel development in Tie1 hypomorphic mice. Development. 137 (2010), 1285-1295.
46. Chen-Konak, L, Y Guetta-Shubin, H Yahav, et al: Transcriptional and posttranslation regulation of the Tiel receptor by fluid shear stress changes in vascular endothelial cells. FASEB J. 17 (2003), 2121-2123.
47. Hansen, TM, H Singh, NP Brindle, et al: Effects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surface. Cell. Signal. 22 (2010), 527-532.
48. Singh, H, CS Milner, MM Aguilar Hernandez, et al: Vascular endothelial growth factor activates the Tie family of receptor tyrosine kinases. Cell. Signal. 21 (2009), 1346-1350.
49. Marron, MB, DP Hughes, MD Edge, et al: Evidence for heterotypic interaction between the receptor tyrosine kinases TIE-1 and TIE-2. J. Biol. Chem. 275 (2000), 39741-39746.
50. Marron, MB, H Singh, TA Tahir, et al: Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2. J. Biol. Chem. 282 (2007), 30509-30517.
51. Yuan, HT, S Venkatesha, SA Karumanchi, et al: Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival. FASEB J. 21 (2007), 3171-3183.
52. Kim, KL, IS Shin, JM Kim, et al: Interaction between Tie receptors modulates angiogenic activity of angiopoietin2 in endothelial progenitor cells. Cardiovasc. Res. 72 (2006), 394-402.
53. Saharinen, P, L Eklund, K Alitalo, et al: Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat. Cell. Biol. 10 (2008), 527-537.
54. Puri, MC, J Rossant, K Alitalo, et al: The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J. 14 (1995), 5884-5891.
55. Sato, TN, Y Tozawa, U Deutsch, et al: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376 (1995), 70-74.
56. D'Amico, G, EA Korhonen, K Alitalo, et al: Loss of endothelial Tie1 receptor impairs lymphatic vessel development-brief report. Arterioscler. Thromb. Vasc. Biol. 30 (2010), 207-209.
57. Dumont, DJ, TP Yamaguchi, ML Breitman, et al: Tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene 7 (1992), 1471-1480.
58. Sato, TN, Y Qin, KL Audus, et al: Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc. Natl. Acad. Sci. U. S. A. 90 (1993), 9355-9358.
59. Nakamura, Y, T Yahata, Y Muguruma, et al: Angiopoietin-1 supports induction of hematopoietic activity in human CD34- bone marrow cells. Exp. Hematol. 35 (2007), 1872-1883.
60. Takakura, N, T Watanabe, T Suda, at al: A role for hematopoietic stem cells in promoting angiogenesis. Cell. 102 (2000), 199-209.
61. Gomei, Y, Y Nakamura, H Yoshihara, et al: Functional differences between two Tie2 ligands, angiopoietin-1 and -2, in regulation of adult bone marrow hematopoietic stem cells. Exp. Hematol. 38 (2009), 82-89.
62. Brown, LF, BJ Dezube, K Tognazzi, et al: Expression of Tiel, Tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. Am. J. Pathol. 156 (2000), 2179-2183.
63. Henrich, I, L Edler, A Sucker, et al: Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma. Clin. Cancer Res. 15 (2009), 1384-1392.
64. De Palma, M, MA Venneri, L Naldini, et al: Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell. 8 (2005), 211-226.
65. Kriehuber, E, S Breiteneder-Geleff, M Groeger, et al: Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp. Med. 194 (2001), 797-808. (Pubitemid 32983015)
66. Petrova, TV, T Mäkinen, K Alitalo, et al: Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J. 21 (2002), 4593-4599.
67. Morisada, T, Y Oike, Y Yamada, et al: Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. Blood 105 (2005), 4649-4656. (Pubitemid 40807284)
68. Tammela, T, A Saaristo, K Alitalo, et al: Angiopoietin-1 promotes lymphatic sprouting and hyperplasia. Blood 105 (2005), 4642-4648. (Pubitemid 40807283)
69. Shimoda, H: Immunohistochemical demonstration of Angiopoietin-2 in lymphatic vascular development. Histochem. Cell Biol. 131 (2009), 231-238.
70. Nishimura, M, T Miki, R Yashima, et al: Angiopoietin-3, a novel member of the angiopoietin family. FEBS Lett. 448 (1999), 254-256. (Pubitemid 29168497)
71. Nakamura, Y, T Yahata, Y Muguruma, et al: Angiopoietin-1 supports induction of hematopoietic activity in human CD34- bone marrow cells. Exp. Hematol. 35 (2007), 1872-1883.
72. Korhonen, J, J Partanen, K Alitalo, et al: Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood 80 (1992), 2548-2555.
73. Partanen, J, E Armstrong, K Alitalo, et al: A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol. Cell. Biol. 12 (1992), 1698-1707.
74. Hughes, DP, MB Marron, NP Brindle, et al: The anti-inflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kappaB inhibitor ABIN-2. Circ. Res. 92 (2003), 630-636.
75. Albrecht, ED, JS Babischkin, GJ Pepe, et al: Regulation of placental villous angiopoietin-1 and -2 expression by estrogen during baboon pregnancy. Mol. Reprod. Dev. 75 (2008), 504-511.
76. Iivanainen, E, L Nelimarkka, V Elenius, et al: Angiopoietin-regulated recruitment of vascular smooth muscle cells by endothelial-derived heparin binding EGF-like growth factor. FASEB J. 17 (2003), 1609-1621.
77. Kobayashi, H, LM DeBusk, YO Babichev, et al: Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment. Blood 108 (2006), 1260-1266. (Pubitemid 44232023)
78. Lindahl, P, BR Johansson, P Leveen, et al: Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277 (1997), 242-245.
79. Hirschi, KK, SA Rohovsky, PA D'Amore, et al: PDGF, TGF beta and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J. Cell. Biol. 141 (1998), 805-814.
80. Oh, SP, T Seki, KA Goss, et al: Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci USA 97 (2000), 2626-2631.
81. Nishishita, T, PC Lin: Angiopoietin 1, PDGF-B, and TGFbeta gene regulation in endothelial cell and smooth muscle cell interaction. J. Cell. Biochem. 91 (2004), 584-593.
82. Winderlich, M, L Keller, G Cagna, et al: VE-PTP controls blood vessel development by balancing Tie-2 activity. J. Cell. Biol. 185 (2009), 657-671.
83. Wouters, V, N Limaye, M Uebelhoer, et al: Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyperphosphorylating effects. Eur. J. Hum. Genet. 18 (2010), 414-420.
84. Limaye, N, V Wouters, M Uebelhoer, et al: Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat. Genet. 41 (2009), 118-124.
85. Kontos, CD, EH Cha, JD York, et al: The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis. Mol. Cell. Biol. 22 (2002), 1704-1713.
86. Kontos, CD, TP Stauffer, WP Yang, et al: Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol. Cell. Biol. 18 (1998), 4131-4140.
87. Fujikawa, K, I de Aos Scherpenseel, L Varticovski, et al: Role of PI 3-kinase in angiopoietin-1-mediated migration and attachment-dependent survival of endothelial cells. Exp. Cell. Res. 253 (1999), 663-672.
88. Gamble, JR, J Drew, MA Vadas, et al: Angiopoietin-1 is an anti-permeability and anti-inflammatory agent in vitro and targets cell junctions. Circ. Res. 87 (2000), 603-607.
89. Kim, I, SO Moon, GY Koh, et al: Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ. Res. 89 (2001), 477-479.
90. Lee, HJ, SW Bae, YS Lee, et al: COMP-Ang1, angiopoietin-1 variant protects radiation-induced bone marrow damage in C57BL/6 mice. J. Radiat. Res. 49 (2008), 313-320.
91. Mammoto, T, SM Parikh, VP Sukhatme, et al: Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo. J. Biol. Chem. 282 (2007), 23910-23918.
92. Suri, C, PF Jones, GD Yancopoulos, et al: Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87 (1996), 1171-1180. (Pubitemid 27010101)
93. Cohen, B, D Barkan, M Rubinstein, et al: Leptin induces angiopoietin-2 expression in adipose tissues. J. Biol. Chem. 276 (2001), 7697-7700.
94. Harfouche, R, SN Hussain: Signaling and regulation of endothelial cell survival by angiopoietin-2. Am. J. Physiol. Heart Circ. Physiol. 291 (2006), H1635-H1645.
95. Eklund, L, BR Olsen: Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp. Cell. Res. 312 (2006), 630-641.
96. Yuan, HT, EV Khankin, SM Parikh, et al: Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol. Cell. Biol. 29 (2009), 2011-2022.
97. Nguyen, VP, SH Chen, DJ Dumont, et al: Differential response of lymphatic, venous and arterial endothelial cells to angiopoietin-1 and angiopoietin-2. BMC Cell. Biol. 6 (2007), 8-10.
98. Carlson, TR, Y Feng, PC Maisonpierre, et al: Direct celladhesion to the angiopoietins mediated by integrins. J. Biol. Chem. 276 (2001), 26516-26525.
99. Dallabrida, SM, N Ismail, JR Oberle, et al: Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins. Circ. Res. 96 (2005), e8-e24.
100. Davis, S, N Papadopoulos, TH Aldrich, et al: Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat. Struct. Biol. 10 (2003), 38-44.
101. Imanishi, Y, B Hu, MJ Jarzynka, et al: Angiopoietin-2 stimulates breast cancer metastasis through the alpha (5) beta (1) integrin-mediated pathway. Cancer Res. 67 (2007), 4254-4263.
102. Cascone, I, L Napione, F Bussolino, et al: Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1. J. Cell. Biol. 170 (2005), 993-1004.
103. Hu, B, MJ Jarzynka, P Guo, et al: Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway. Cancer Res. 66 (2006), 775-783.
104. Wu, Y, L Chen, PS Zheng, et al: Beta 1-integrin-mediated glioma cell adhesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PGM/versican. J. Biol. Chem. 277 (2002), 12294-12301.
105. Takakura, N, XL Huang, T Naruse, et al: Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity 9 (1998), 677-686. (Pubitemid 28557596)
106. Huang, XZ, JF Wu, R Ferrando, et al: Fatal bilateral chylothorax in mice lacking the integrin alpha9betal. Mol. Cell. Biol. 20 (2000), 5208-5215.
107. Wang, JF, XF Zhang, JE Groopman, et al: Stimulation of beta 1 integrin induces tyrosine phosphorylation of vascular endothelial growth factor receptor-3 and modulates cell migration. J. Biol. Chem. 276 (2001), 41950-41957.
108. Zagzag, D, A Hooper, DR Friedlander, et al: In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Exp. Neurol. 159 (1999), 391-400.
109. Stratmann, A, W Risau, KH Plate, et al: Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am. J. Pathol. 153 (1998), 1459-1466.
110. Goede, V, T Schmidt, S Kimmina, et al: Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab. Invest. 78 (1998), 1385-1394.
111. Oh, H, H Takagi, K Suzuma, et al: Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovin microvascular endothelial cells. J. Biol. Chem. 274 (1999), 15732-15739.
112. Kim, I, JH Kim, YS Ryu, et al: Tumor necrosis factoralpha upregulates angiopoietin-2 in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 269 (2000), 361-365.
113. Huang, YQ, JJ Li, L Hu, et al: Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells. Blood 99 (2002), 1646-1650.
114. Pichiule, P, JC Chavez, JC LaManna, et al: Hypoxic regulation of angiopoietin-2 expression in endothelial cells. J. Biol. Chem. 279 (2004), 12171-12180.
115. Mandriota, SJ, MS Pepper: Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ. Res. 83 (1998), 852-859.
116. Krikun, G, F Schatz, T Finlay, et al: Expression of angiopoietin-2 by human endometrial endothelial cells: Regulation by hypoxia and inflammation. Biochem. Biophys. Res. Commun. 275 (2000), 159-163.
117. Yamakawa, M, LX Liu, T Date, et al: Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ. Res. 93 (2003), 664-673.
118. Hegen, A, S Koidl, K Weindel, et al: Expression of angiopoietin-2 in endothelial cells is controlled by positive and negative regulatory promoter elements. Arterioscler. Thromb. Vasc. Biol. 24 (2004), 1803-1809.
119. Lund, EL, A Hog, MW Olsen, et al: Differential regulation of VEGF, HIF1alpha and angiopoietin-1, -2 and -4 by hypoxia and ionizing radiation in human glioblastoma. Int. J. Cancer 108 (2004), 833-838.
120. Shim, WS, IA Ho, PE Wong, et al: Angiopoietin: A TIE (d) balance in tumor angiogenesis. Mol. Cancer Res. 5 (2007), 655-665.
121. Tait CR, PF Jones: Angiopoietins in tumours: The angiogenic switch. J. Pathol. 204 (2004), 1-10.
122. Daly, C, E Pasnikowski, E Burova, et al: Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells. Proc. Natl. Acad. Sci. USA 103 (2006), 15491-15496.
123. Daly, C, W Wong, E Burova, et al: Angiopoietin-1 modulates endothelial cellfunction and gene expression via the transcription factor FKHR (FOXO1). Genes Dev. 18 (2004), 1060-1071. (Pubitemid 38620245)
124. Tsigkos, S, Z Zhou, A Kotanidou, et al: Regulation of Ang2 release by PTEN/PI3-kinase/Akt in lung microvascular endothelial cells. J. Cell Physiol. 207 (2006), 506-511.
125. Xue, Y, R Cao, D Nilsson, et al: FOXC2 controls Ang-2 expression and modulates angiogenesis, vascular patterning, remodeling, and functions in adipose tissue. Proc. Natl. Acad. Sci USA 105 (2008), 10167-10172.
126. Ye, F, M Florian, SA Magder, et al: Regulation of angiopoietin and Tie-2 receptor expression in non-reproductive tissues by estrogen. Steroids 67 (2002), 305-310.
127. Yao, D, T Taguchi, T Matsumura, et al: High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3 A. J. Biol. Chem. 282 (2007), 31038-31045.
128. McCarthy, MJ, M Crowther, PR Bell, et al: The endothelial receptor tyrosine kinase tie-1 is upregulated by hypoxia and vascular endothelial growth factor. FEBS Lett. 42 (1998), 334-338. (Pubitemid 28129360)
129. Wen, CY, M Ito, I Sekine, et al: IL-11 up-regulates Tie-2 expression during the healing of gastric ulcers in rats. World J. Gastroenterol. 9 (2003), 788-790.
130. Metheny-Barlow, LJ, S Tian, LY Li, et al: Direct chemotactic action of angiopoietin-1 on mesenchymal cells in the presence of VEGF. Microvasc. Res. 68 (2004), 221-230.
131. Dube, A, S Thai, P Oettgen, et al: Elf-1 is a transcriptional regulator of the Tie2 gene during vascular development. Circ. Res. 88 (2001), 237-244.
132. Dumont, DJ, G Gradwohl, GH Fong, et al: Dominant negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8 (1994), 1897-1909.
133. Patan, S: TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth. Microvasc. Res. 56 (1998), 1-21.
134. Teichert-Kuliszewska, K, PC Maisonpierre, DJ Stewart, et al: Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2. Cardiovasc. Res. 49 (2001), 659-670.
135. Hammes, HP, J Lin, P Wagner, et al: Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes 53 (2004), 1104-1110.
136. Feng, Y, F vom Hagen, HP Hammes, et al: Impaired pericyte recruitment and abnormal retinal angiogenesis as a result of angiopoietin-2 overexpression. Thromb. Haemost. 97 (2007), 99-108.
137. Koga, K, T Todaka, M Morioka, et al: Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis. Cancer Res. 61 (2001), 6248-6254. (Pubitemid 32762564)
138. Machein, MR, A Knedla, R Knoth, et al: Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model. Am. J. Pathol. 16 (2004), 1557-1570.
139. Falcon, BL, H Hashizume, P Koumoutsakos, et al: Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels. Am. J. Pathol. 175 (2009), 2159-2170.
140. Brown, JL, ZA Cao, DC Blakey, et al: A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models. Mol. Cancer Ther. 9 (2010), 145-156.
141. Mäkinen, T, T Veikkola, K Alitalo, et al: Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 20 (2001), 4762-4773.
142. Irrthum, A, J Marika, M Vikkula, et al: Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am. J. Hum. Genet. 67 (2000), 295-301.
143. Hackett, SF, S Wiegand, PA Campochiaro, et al: Angiopoietin-2 plays an important role in retinal angiogenesis. J. Cell. Physiol. 192 (2002), 182-187.
144. Petrova, TV, T Karpanen, K Alitalo, et al: Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat. Med. 10 (2004), 974-981.
145. Fang, J, SL Dagenais, RP Erickson, et al: Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am. J. Hum. Genet. 67 (2000), 1382-1388.
146. Kobayashi, H, LM DeBusk, YO Babichev, et al: Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment. Blood 108 (2006), 1260-1266. (Pubitemid 44232023)
147. Uemura, A, M Ogawa, M Hirashima, et al: Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J. Clin. Invest. 11 (2002), 1619-1628.
148. Seegar, TC, B Eller, D Tzvetkova-Robev, et al: Tiel-Tie2 Interactions mediate functional differences between angiopoietin ligands. Molec. Cell 37 (2010), 643-655.
149. Partanen, J, DJ Dumont: Functions of Tie1 and Tie2 receptor tyrosine kinases in vascular development. Curr. Top. Microbiol. Immunol. 237 (1999), 159-172.
150. Porat, RM, M Grunewald, A Globerman, et al: Specific induction of tie1 promoter by disturbed flow in atherosclerosis-prone vascular niches and flow-obstructing pathologies. Circ. Res. 94 (2004), 394-401.
151. Ganta, VC, W Cromer, JS Alexander, et al: Angiopoietin-2 in experimental colitis. Inflamm. Bowel Dis. 16 (2010), 1029-1039.